BackAdc Therapeutics SA Overview
Adc Therapeutics SA

Adc Therapeutics SA Target Price

Analysts' average 12-month price target for Adc Therapeutics SA is $3.5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.23

Average Target Price

$3.50184.6% upside

2 analysts in the last 4 months

High: $5 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-04StephensSudan Loganathan$5306.5% upsideOpen
2026-06-04RBC Capital$262.6% upsideOpen
2025-12-03RBC CapitalGregory Renza$5306.5% upsideOpen
2025-11-12GuggenheimMichael Schmidt$10713% upsideOpen
2024-05-07H.C. WainwrightRobert Burns$8550.4% upsideOpen
2024-03-13JefferiesKelly Shi$13956.9% upsideOpen
2022-11-14Morgan Stanley$7469.1% upsideOpen
2022-09-09Morgan StanleyMatthew Harrison$11794.3% upsideOpen
2022-08-22H.C. Wainwright$201526% upsideOpen

Adc Therapeutics SA (ADCT) FAQ

Adc Therapeutics SA's target price stands at $3.5. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $3.5 for ADCT implies 184.6% upside versus today's price ($1.23). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Adc Therapeutics SA's target price evolved across reporting periods, while the comparison chart places ADCT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Adc Therapeutics SA's reading of $3.5 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.